The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety results of NRG-LU004: Phase I trial of accelerated or conventionally fractionated radiotherapy combined with durvalumab in PD-L1–high locally advanced non-small cell lung cancer.
 
Steven H. Lin
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Scenexo
Honoraria - AstraZeneca/MedImmune; BeyondSpring Pharmaceuticals
Consulting or Advisory Role - Scenexo
Speakers' Bureau - AstraZeneca
Research Funding - BeyondSpring Pharmaceuticals; Nektar; STCube Pharmaceuticals Inc.
Travel, Accommodations, Expenses - Elekta; STCube Pharmaceuticals Inc.
 
Stephanie L. Pugh
Research Funding - Millennium (Inst); Pfizer (Inst)
 
Anne S. Tsao
Consulting or Advisory Role - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Epizyme; Genentech/Roche; HERON; Lilly; Novartis; Takeda
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Merck; Millennium; Polaris; Seagen; Seagen; Takeda
Patents, Royalties, Other Intellectual Property - UptoDate
 
Martin Joseph Edelman
Stock and Other Ownership Interests - Biomarker Strategies
Consulting or Advisory Role - e-doctor healthcare reviews; Flame Biosciences; Kanaph Therapeutics; Precision Oncology; Proventus Group; Sanofi/Regeneron; WindMIL
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Nektar (Inst); United Therapeutics (Inst); Windmil (Inst)
Patents, Royalties, Other Intellectual Property - Patent application for radiopharmaceutical to treat small cell lung cancer. (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - AstraZeneca/MedImmune; Boehringer Ingelheim; Seagen; Takeda
 
Anthony Doemer
Consulting or Advisory Role - ViewRay
 
Charles B. Simone
Honoraria - Varian Medical Systems
 
Saumil Gandhi
No Relationships to Disclose
 
Sai Bikkina
No Relationships to Disclose
 
Nagla Fawzy Abdel Karim
Stock and Other Ownership Interests - Abbott Biotherapeutics (I)
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Sanofi/Regeneron
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb/Pfizer; Exelixis; Pfizer
Expert Testimony - Exosome Diagnostics
 
Xinglei Shen
No Relationships to Disclose
 
Shahed N Badiyan
No Relationships to Disclose
 
Kristin Ann Higgins
Honoraria - PrecisCA
Consulting or Advisory Role - AstraZeneca; Genentech; Varian Medical Systems
Research Funding - Jazz Pharmaceuticals; Reflexion Medical
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca
 
Arnab Chakravarti
Research Funding - Varian Medical Systems (Inst)
 
Maria Werner-Wasik
Stock and Other Ownership Interests - Illumina (I)
Honoraria - AstraZeneca
Patents, Royalties, Other Intellectual Property - signal transduction inhibitor in lymphoma (I)
 
John M Schellenkamp
No Relationships to Disclose
 
Rebecca Paulus
No Relationships to Disclose
 
Jeffrey D. Bradley
Honoraria - AstraZeneca/MedImmune; Mevion Medical Systems
Consulting or Advisory Role - Genentech; Varian Medical Systems